Dose–response relationship between serum fibroblast growth factor 21 and liver fat content in non-alcoholic fatty liver disease
Fangsen Xiao, Xiulin Shi, Peiying Huang, Xianglong Zeng, L. Wang, Jingyu Zeng, Chia‐Chen Liu, Bing Yan, Hang Song, Yang Xu, L. Han, Qiuyang Zhao, Mingzhu Lin, X. Li
Topics & Concepts
FGF21Internal medicineFatty liverMedicineQuartileTriglycerideEndocrinologyObesityGastroenterologyDiseaseFibroblast growth factorCholesterolConfidence intervalReceptorFibroblast Growth Factor ResearchLiver Disease Diagnosis and TreatmentParathyroid Disorders and Treatments